Aufenacker T J, Koelemay M J W, Gouma D J, Simons M P
Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Br J Surg. 2006 Jan;93(1):5-10. doi: 10.1002/bjs.5186.
The aim was to determine whether systemic antibiotic prophylaxis prevented wound infection after repair of abdominal wall hernia with mesh.
This was a systematic review of the available literature identified from multiple databases using the terms 'hernia' and 'antibiotic prophylaxis'. Randomized placebo-controlled trials of antibiotic prophylaxis in abdominal wall mesh hernia repair with explicitly defined wound infection criteria and a minimum follow-up of 1 month were included. After independent quality assessment and data extraction, data were pooled for meta-analysis using a random-effects model.
The search process identified eight relevant trials. Two papers on umbilical, incisional or laparoscopic hernias, and six concerning inguinal and femoral (groin) hernias were suitable for meta-analysis. The incidence of infection after groin hernia repair was 38 (3.0 per cent) of 1277 in the placebo group and 18 (1.5 per cent) of 1230 in the antibiotic group. Antibiotic prophylaxis did not significantly reduce the incidence of infection: odds ratio 0.54 (95 per cent confidence interval 0.24 to 1.21); number needed to treat was 74. The number of deep infections was six (0.6 per cent) in the placebo group and three (0.3 per cent) in the antibiotic prophylaxis group: odds ratio 0.50 (95 per cent c.i. 0.12 to 2.09).
Antibiotic prophylaxis did not prevent the occurrence of wound infection after groin hernia surgery. More trials are needed for complete evidence in other areas of abdominal wall hernia.
目的是确定全身应用抗生素预防能否降低使用补片修补腹壁疝后伤口感染的发生率。
这是一项系统评价,通过使用检索词“疝”和“抗生素预防”从多个数据库中识别可用文献。纳入了腹壁补片疝修补术中抗生素预防的随机安慰剂对照试验,这些试验具有明确界定的伤口感染标准且最短随访时间为1个月。经过独立的质量评估和数据提取后,使用随机效应模型对数据进行汇总以进行荟萃分析。
检索过程共识别出八项相关试验。两篇关于脐疝、切口疝或腹腔镜疝的论文,以及六篇关于腹股沟疝和股疝(腹股沟区)的论文适合进行荟萃分析。腹股沟疝修补术后安慰剂组1277例中有38例(3.0%)发生感染,抗生素组1230例中有18例(1.5%)发生感染。抗生素预防并未显著降低感染发生率:比值比为0.54(95%置信区间为0.24至1.21);需治疗人数为74。安慰剂组深部感染例数为6例(0.6%),抗生素预防组为3例(0.3%):比值比为0.50(95%置信区间为0.12至2.09)。
抗生素预防不能预防腹股沟疝手术后伤口感染的发生。在腹壁疝的其他领域需要更多试验以获得完整证据。